MedPath

The Effect of Lifestyle-Adjustments Prior to Medical Treatment on the Effect of Medical Treatment in Reflux Patients

Completed
Conditions
GERD
Quality of Life
Registration Number
NCT00524251
Lead Sponsor
AstraZeneca
Brief Summary

The purpose of this study is to determine whether the improvement in the quality of life after an initial treatment with esomeprazole 40mg for reflux disease is the same in patients who have already made lifestyle-adjustments as in patients who have not implemented lifestyle-adjustments prior to the start of treatment (baseline)

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
990
Inclusion Criteria
  • Patients with reflux complaints
  • 18 years of age
Exclusion Criteria
  • Restrictions as mentioned in the registration text
  • H2RA or PPI use in the month prior to inclusion

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Research Site

🇳🇱

Zoetermeer, Netherlands

© Copyright 2025. All Rights Reserved by MedPath